Skip To Main Content
Khen Elazar on Muck Rack

Khen Elazar

Tel Aviv
As seen in: Seeking Alpha, MSN, NewsBreak, citybiz
Strategic consultant, stock analyst, and writer. Loves traveling, sports, politics, food, music, and finance in that order 🇮🇱 🇺🇸
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Khen

Contact Khen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Air Products & Chemicals Stock: A Key Player In Energy Transition (NYSE:APD) Original

|
By Khen Elazar
| Seeking Alpha
Introduction One sector that I lack exposure to is the basic materials sector. While I have adequate exposure to the energy sector, the basic materials remain elusive. As companies in the sector tend to be sensitive to price changes of commodities, most of them are unsuitable for dividend growth investors seeking reliable growth in sales and EPS. In this article, I will analyze Air Products and Chemicals (NYSE:APD), a leading dividend aristocrat in the sector.
Open in Who Shared View Duplicates (3) Issue with article?

Visa Is Expensive, But Still A Buy (NYSE:V)

|
By Khen Elazar
| Seeking Alpha
Introduction I recently wrote about American Express (AXP) as an exciting investment option in financial services. One of the comments I got asked me about the difference between American Express and Visa (NYSE:V). Visa is focused on the infrastructure of transactions and doesn't offer credit like American Express. However, some parts of their business still overlap, such as payments. Therefore, they are competing in some competitive arenas.
Open in Who Shared Issue with article?

Despite Humira's Challenges, AbbVie Stock's Execution Makes It A Buy (NYSE:ABBV)

|
By Khen Elazar
| Seeking Alpha
Introduction The healthcare sector has always been fascinating to me. It combines innovative approaches that can achieve a significant premium for its products with essential products. Therefore, these companies tend to be more resilient to economic uncertainties. One such company is AbbVie (NYSE:ABBV), which I analyzed almost two years ago. I hold shares in the company in my dividend growth portfolio.
Open in Who Shared Issue with article?
See all 484 articles